Survivorship of the Souter-Strathclyde elbow replacement in the young inflammatory arthritis elbow.
We divided 309 patients with an inflammatory arthritis who had undergone primary elbow replacement using the Souter-Strathclyde implant into two groups according to their age. The mean follow-up in the older group (mean age 64 years) was 7.3 years while in the younger patients (mean age 42 years) it was 12 years. Survivorship for three different failure end-points (revision, revision because of aseptic loosening of the humeral component, and gross loosening of the humeral implant), was compared in both groups. Our findings showed that there was no significant difference in the incidence of loosening when young rheumatoid patients were compared with an older age group.
Talwalkar
S C
SC
Wrightington Hospital, Hall Lane, Wigan WN6 9EP, UK. stalwalkar@aol.com
Givissis
P K
PK
Trail
I A
IA
Nuttall
D
D
Stanley
J K
JK
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000503:physiopathology / Q000601:surgery*; D019643:Arthroplasty, Replacement / Q000379:methods*; D004551:Elbow Joint / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007595:Joint Prosthesis; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000503:physiopathology; D011183:Postoperative Complications; D016059:Range of Motion, Articular / Q000502:physiology; D012307:Risk Factors; D016896:Treatment Outcome